Target intelligence / Profile preview

Component of oligomeric Golgi complex subunit 2 (COG2)

Target
COG2
Molecular classification
Other (subunit of a tethering complex), Vesicular transport protein, Golgi complex subunit
01

Overview

Component of oligomeric Golgi complex subunit 2 (COG2) is a protein-coding gene that encodes a subunit of the conserved oligomeric Golgi (COG) complex, which is essential for maintaining the normal structure and activity of the Golgi apparatus. The COG complex, including COG2, facilitates retrograde vesicular trafficking within the Golgi and is required for proper glycoprotein modification and enzyme localization. Mutations in COG2 can cause congenital disorders of glycosylation, leading to defects in protein glycosylation and associated clinical syndromes. COG2 operates by mediating the initial physical contact between transport vesicles and their membrane targets, akin to other Golgi tethering complexes. There are no approved or known drugs targeting COG2, and it is not considered a classical therapeutic target, receptor, enzyme, or transporter.

Other names
Conserved oligomeric Golgi complex subunit 2LDLCCDG2QCOG complex subunit 2Low density lipoprotein receptor defect C-complementing proteinbrefeldin A-sensitive peripheral Golgi proteinconserved oligomeric Golgi complex protein 2low density lipoprotein receptor defect C-complementing protein
02

Biological functions

Maintenance of Golgi apparatus structure and functionIntracellular vesicle-mediated transportGolgi enzyme traffickingGlycoprotein modificationProtein-containing complex binding
03

Disease associations

Congenital disorder of glycosylation, type IIq (COG2-CDG)Congenital disorder of glycosylation, type In

Beyond the preview

Go deeper on Component of oligomeric Golgi complex subunit 2 (COG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Component of oligomeric Golgi complex subunit 2 (COG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call